Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00272324 · ClinicalTrials.gov registry record · Phase 2

Aspirin/Folate Prevention of Large Bowel Polyps

A Phase 2 study, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
Phase 2
Development phase
1,121
Enrollment target

NCT00272324: Completed Phase 2 study, sponsored by Dartmouth-Hitchcock Medical Center.

NCT00272324 is a Phase 2 study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 1,121 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (743% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00272324, a Phase 2 study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
Phase 2
Development phase
1,121 participants
Enrollment target

Study Summary

This is a randomized controlled trial of aspirin and/or folate supplementation for the prevention of the recurrence of neoplastic polyps (adenomas) of the large bowel.

Primary Outcome

colorectal adenomas detected at follow-up colonoscopy

Interventions

  • DRUG Aspirin
  • DRUG Folate

Trial Details

FieldValue
Enrollment Target 1,121 participants
Start Date 1992-02
Est. Completion 2007-01
Phase Phase 2
Dartmouth-Hitchcock Medical Center

427 total trials

What the finished NCT00272324 record still lists

NCT00272324 is an interventional study that assigns participants to a tested intervention. Its 1,121 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (743% higher).

The record links to 0 conditions, and to 2 interventions - of which Aspirin is the first listed.

NCT00272324 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00272324 about?

NCT00272324 is a clinical study titled "Aspirin/Folate Prevention of Large Bowel Polyps". This is a randomized controlled trial of aspirin and/or folate supplementation for the prevention of the recurrence of neoplastic polyps (adenomas) of the large bowel.

What is the current status of trial NCT00272324?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,121 participants. The study started on 1992-02. Estimated completion is 2007-01.

What interventions are being tested in trial NCT00272324?

The interventions under investigation include: Aspirin (DRUG), Folate (DRUG).

Who is sponsoring clinical trial NCT00272324?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00272324's enrollment target sits among peer trials

1,121 20th of 2000 higher than 1,981 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05691478 · 1,122 participants · Phase 2

    A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

  • NCT02140255 · 1,120 participants · Phase 1

    Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

  • NCT06618534 · 1,120 participants · Phase 2

    Azithromycin for Meningococcal Carriage

  • NCT07164131 · 1,120 participants · Phase 4

    Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00272324, the US trial registry maintained by the National Library of Medicine. NCT00272324 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.